Pharmacogenomic testing for angiotensin-converting enzyme inhibitors: getting ready for prime time.
Simon
S
de Denus
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D000818:Animals; D005820:Genetic Testing / Q000379:methods* / Q000639:trends*; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends*; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000502:physiology; D013997:Time Factors
C544065:AGTR1 protein, human; D000806:Angiotensin-Converting Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1